Hyperbilirubinemia following lenalidomide administration

Asymptomatic hyperbilirubinemia in a patient with no underlying liver disease or renal impairment while on lenalidomide therapy may be attributable to the unmasking of previously undiagnosed Gilbert's syndrome, as previously shown in the literature. The hyperbilirubinemia should resolve after d...

Descripción completa

Detalles Bibliográficos
Autores principales: Azmy, Veronica, Neparidze, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930194/
https://www.ncbi.nlm.nih.gov/pubmed/29744077
http://dx.doi.org/10.1002/ccr3.1471
_version_ 1783319458476982272
author Azmy, Veronica
Neparidze, Natalia
author_facet Azmy, Veronica
Neparidze, Natalia
author_sort Azmy, Veronica
collection PubMed
description Asymptomatic hyperbilirubinemia in a patient with no underlying liver disease or renal impairment while on lenalidomide therapy may be attributable to the unmasking of previously undiagnosed Gilbert's syndrome, as previously shown in the literature. The hyperbilirubinemia should resolve after discontinuation of the drug.
format Online
Article
Text
id pubmed-5930194
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-59301942018-05-09 Hyperbilirubinemia following lenalidomide administration Azmy, Veronica Neparidze, Natalia Clin Case Rep Case Reports Asymptomatic hyperbilirubinemia in a patient with no underlying liver disease or renal impairment while on lenalidomide therapy may be attributable to the unmasking of previously undiagnosed Gilbert's syndrome, as previously shown in the literature. The hyperbilirubinemia should resolve after discontinuation of the drug. John Wiley and Sons Inc. 2018-03-13 /pmc/articles/PMC5930194/ /pubmed/29744077 http://dx.doi.org/10.1002/ccr3.1471 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Azmy, Veronica
Neparidze, Natalia
Hyperbilirubinemia following lenalidomide administration
title Hyperbilirubinemia following lenalidomide administration
title_full Hyperbilirubinemia following lenalidomide administration
title_fullStr Hyperbilirubinemia following lenalidomide administration
title_full_unstemmed Hyperbilirubinemia following lenalidomide administration
title_short Hyperbilirubinemia following lenalidomide administration
title_sort hyperbilirubinemia following lenalidomide administration
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930194/
https://www.ncbi.nlm.nih.gov/pubmed/29744077
http://dx.doi.org/10.1002/ccr3.1471
work_keys_str_mv AT azmyveronica hyperbilirubinemiafollowinglenalidomideadministration
AT neparidzenatalia hyperbilirubinemiafollowinglenalidomideadministration

Ejemplares similares